Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04502706
Title Study of FSI-189 as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications

marginal zone B-cell lymphoma

B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

FSI-189

FSI-189 + Rituximab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.